The abstract is read at the publisher; the summary is JClub's.
MYC-driven mammary gland tumor lung metastases show increased glutathione synthesis fueled by higher cystine uptake, revealing a cystine/cysteine metabolic dependency.
- Why it matters: Metastatic spread involves organ-specific metabolic rewiring, but the vulnerabilities of lung-disseminated breast cancer cells are not well defined for targeted therapy.
- What they did: Using stable isotope-resolved metabolomics, mass spectrometry imaging, and single-cell RNA sequencing in in vivo and ex vivo MYC-driven models, the study linked cystine uptake to reliance on extracellular cysteine or cystine.
- The result: In combination with focal radiotherapy, the amino acid degrader cyst(e)inase reduced lung metastatic burden, suggesting cystine/cysteine targeting can sensitize metastases to oxidative stress.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.